Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent

NACompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

August 31, 2014

Conditions
AtherosclerosisCoronary Artery Disease
Interventions
DEVICE

PROMUS Element Coronary Stent System

Everolimus-eluting Coronary Stent Drug-eluting Stent (DES) implantation

DEVICE

TAXUS Liberté Coronary Stent System

Paclitaxel-eluting Coronary Stent Drug-eluting Stent (DES) implantation

Trial Locations (15)

Unknown

Cardiovascular Institute and Fu Wai Hospital, Beijing

Peking Union Medical College Hospital, Beijing

Peking University First Hospital, Beijing

The Chinese People's Liberation Army General Hospital, Beijing

Huaxi Hospital of Sichuan University, Chengdu

Daqing General Oil Field Hospital, Daqing

Guangdong Cardiovascular Institute of Guangdong Provincial Hospital, Guangzhou

Guangdong Nanfang Hospital, Guangzhou

The 2nd Affiliated Hospital of Harbin Medical University, Harbin

Nanjing First Hospital, Nanjing

Shanghai 6th People's Hospital, Jiaotong University, Shanghai

Shanghai Chest Hospital of Jiaotong University, Shanghai

General Hospital of SY Military Institute, Shenyang

TEDA International Cardiovascular Hospital, Tianjin

Xijing Hospital, Fourth Military Medical University, Xi'an

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY